Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis-Reference-Cited by-同舟云学术

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

Published:2005-11 Issue:11 Volume:12 Page:817-827
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Sorensen P. S.,Deisenhammer F.,Duda P.,Hohlfeld R.,Myhr K.-M.,Palace J.,Polman C.,Pozzilli C.,Ross C.,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2005.01386.x/fullpdf

Reference63 articles.

1. Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

2. Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

3. Interferon β neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations

4. Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials;Hepatology;2024-04-17

2. ADAR Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy;Global Medical Genetics;2023-07-10

3. Immunopathology of multiple sclerosis;Translational Neuroimmunology, Volume 8;2023

4. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19

5. Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis;Frontiers in Immunology;2020-10-15